| Tami Renai Moore, MD | |
|
1700 Mount Vernon Ave, Bakersfield, CA 93306 | |
| (661) 326-2168 | |
| (510) 504-1044 |
| Full Name | Tami Renai Moore |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 1700 Mount Vernon Ave, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447619945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A143915 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital Of San Bernardino | San bernardino, CA | Hospital |
| Parkview Community Hospital Medical Center | Riverside, CA | Hospital |
| St Mary Medical Center | Apple valley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
| Riverside Emergency Physicians Medical Group | 0547173882 | 19 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Pleasanton Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285625509 PECOS PAC ID: 0143118927 Enrollment ID: O20040304001270 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Riverside Emergency Physicians Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972539039 PECOS PAC ID: 0547173882 Enrollment ID: O20040729001307 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Altamont Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392375 PECOS PAC ID: 5496700759 Enrollment ID: O20050318000840 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Montclair Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316044696 PECOS PAC ID: 8022019702 Enrollment ID: O20070123000593 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | San Dimas Emergency Medical Associates Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720239460 PECOS PAC ID: 0648334235 Enrollment ID: O20090127000007 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Pinnacle Emergency Physicians Of Bakersfield, A Professional Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619153251 PECOS PAC ID: 7214086321 Enrollment ID: O20090520000375 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Chino Emergency Medical Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013282029 PECOS PAC ID: 9638334410 Enrollment ID: O20120628000341 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Corona Regional Emergency Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134629298 PECOS PAC ID: 9133481484 Enrollment ID: O20180326001396 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Seton Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001202 PECOS PAC ID: 4789948969 Enrollment ID: O20180516001793 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Entity Name | Nes Western Group A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487125019 PECOS PAC ID: 4587902952 Enrollment ID: O20190208002821 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tami Renai Moore, MD 1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 Ph: (661) 326-2168 | Tami Renai Moore, MD 1700 Mount Vernon Ave, Bakersfield, CA 93306 Ph: (661) 326-2168 |
News Archive
The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
› Verified 2 days ago
Dr. Shannon K. Grant, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-663-6275 Fax: 661-326-8022 | |
Dr. Michael Darin Niedens, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1830 Flower St, Bakersfield, CA 93305 Phone: 661-326-2667 | |
Rick Daniel Ornum Figurasin, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2615 Chester Ave, Bakersfield, CA 93301 Phone: 661-869-6227 | |
Albert Ko, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9900 Stockdale Hwy, Suite 105, Bakersfield, CA 93311 Phone: 661-410-9500 | |
Lev Libet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Trailer #2 Dept Of Emergency Medicine, Bakersfield, CA 93306 Phone: 661-326-2168 | |
Dr. Adria Elene Ottoboni, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 Fax: 661-326-2165 | |
Dr. John Eric Fortenberry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Old River Rd, Bakersfield, CA 93311 Phone: 661-326-8021 Fax: 661-326-8022 |